Clinical trial registry record

Identification of Relevant Biological, Imaging, Mobility and Clinical Markers for Clinical Research in Sarcopenia

A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Completed.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated July 31, 2024.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT04569487
Last registry update
July 31, 2024
Status
Completed
Phase
Phase not reported
Sponsor
Artialis
Enrollment
16
Countries
Belgium
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
NON RANDOMIZED · PARALLEL · DIAGNOSTIC · NONE
Evidence population
Human clinical study registration
Participants
16
Population
MALE · 65 Years
Duration
2021-02-11 to 2024-04-02
Intervention
Biopsy
Comparator
Sarcopenic population; Non sarcopenic population
Outcomes measured
Identified soluble markers of sarcopenia — 3 months after biopsy; Identified imaging marker — within 15 days after Day 0 (baseline visit); Determine thePhysical performance — Day 0 (baseline visit); Determine the falls risk — Day 0 (baseline visit); Identified clinical marker — Day 0 (baseline visit); Determine the muscle strength — Day 0 (baseline visit); Evaluate the quality of life — Day 0 (baseline visit); Determine cognitive performance — Day 0 (baseline visit); Determine the nutrition status — Day 0(baseline visit); Evaluate the tolerance — 3 months (baseline visit to biopsy)
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Sarcopenia · 100%Title contains controlled term: sarcopenia. Source terminology contains: sarcopenia. Title supplies longevity context: aging. Study type is explicitly identified as INTERVENTIONAL.

Automated source check 100% · update recency 65%. These figures help sort records; they are not medical ratings.

sarcopenia
Open primary sourceExport JSON